Amarin Corporation is a pharmaceutical company focused on developing and pursuing additional therapeutics to cost-effectively address cardiovascular health worldwide. At Amarin, we are committed to the millions of people across the world at risk of …

1 day ago · DUBLIN and BRIDGEWATER, N.J., March 12, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the fourth quarter of 2024 and provided a review of ...

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. [1] The company develops and markets medicines for the treatment of cardiovascular disease.

1 day ago · Amarin Corporation plc. 1-For-20 Ratio Change Initiated to Increase Per Share Market Price of Amarin’s ADSs in Effort to Maintain Nasdaq Listing

1 day ago · Amarin Corporation plc -- Company Reports Fourth Quarter 2024 Total Revenues of $62.3 Million, Operating Expenses of $43.0 Million and Year End 2024 Cash Position of $294.2 Million --

Learn more about Amarin’s history, leadership, global partnership and its BOLD focus on stopping cardiovascular disease from being a leading cause of death.

2 days ago · Shares of Amarin Corp. hiked up 5.4% in premarket trading Monday, after the drug maker said it would reduce its workforce by 40% as part of its plan to cut operating costs by $100 million over...

Amarin Corporation plc (AMRN) - Yahoo Finance

Amarin is a global pharmaceutical company, focused on addressing cardiovascular health. We apply science, passion, and our global resources to support our BOLD vision to stop cardiovascular disease from being a leading cause of death …

Amarin Corporation is a rapidly growing innovative pharmaceutical company, focused on developing and pursuing additional therapeutics to cost-effectively address cardiovascular health worldwide. At Amarin, we are committed to the millions of people across the world at risk of suffering from a heart attack or stroke.